Funded Tech Companies

Reprieve Cardiovascular

Wondering who backed Reprieve Cardiovascular? Genesis Capital Advisors, Deerfield Management Company and Sante Ventures joined the equity holders in this medical devices company.

Company Overview

Contact Information

Company Background Information

Overview

Reprieve Cardiovascular is a pioneering medical device company focused on improving outcomes for patients suffering from acute decompensated heart failure (ADHF). The company's Reprieve technology is being investigated as an innovative fluid management therapy.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/20/2024

Financing History

Management Team

Title

Name

Email & Social

Chairman

Alexander Martin

        

Chief Executive Officer

James Dillon

        

Chief Medical Officer

Howard Levin

        

Chief Technical Officer

Andrew Halpert

        

VP - Bus. Development

Gregory Mann

        

VP - Operations

Kenneth Luppi

        

Company Investors

• Genesis Capital Advisors
• Deerfield Management Company
• Sante Ventures
• Arboretum Ventures
• Lightstone Ventures
• Abiomed

Browse more funded tech companies:

REPP | Reprise

Share this article

About Our VC Deals Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary